- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Arizona Blood & Cancer Specialists, OneOncology, TMC Healthcare Open 2 Radiation Oncology Centers
Arizona Blood and Cancer Specialists, OneOncology, and TMC HealthCare announce 2 free-standing imaging centers.
Tucson, AZ., March 8, 2021 — Arizona Blood and Cancer Specialists, OneOncology, and TMC HealthCare announced that through their joint venture, they have opened 2 new, free-standing centers focused on radiation oncology and advanced diagnostic imaging.
The newest facility, which opened on March 1, is located at 3700 E. Fort Lowell Road, Suite 130, Tucson, Arizona. Services there will include sophisticated, integrated technologies for planning and delivering high-precision image-guided radiosurgery using Varian’s Edge radiosurgery system. Adding radiation oncology services will open the door for treatment options for patients who may not have had other options and will give their team of oncologists new tools for treating more types of cancer including those that are typically hard to treat.
The site will also utilize GE’s Discovery IQ system for molecular imaging. This superior technology will provide physicians with high-quality images and accurate quantitative information, giving them the ability to find and treat cancer sooner.
The second location in Green Valley that opened in the fall of 2020, is located at 121 W. Esperanza Blvd., Suite 181. In addition to medical oncology, hematology and palliative care that ABCS provides, the joint venture also expanded treatment options along the continuum of care for patients by adding radiation oncology services.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
